The Senate Finance Committee leadership is planning to mark up drug pricing legislation that would be part of a $3.5 trillion infrastructure bill on Sept. 14 “if not even sooner” to accommodate the aggressive timeline set by the House for voting on the bill, according to a committee staffer.
“We’ll start seeing language in the next few weeks” from the committee on drug pricing reform and “whether that’s where...
Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?